Moreover, higher sensitivity in identifying early stages of ovarian cancer was exhibited by HOXA9, HIC1, and SOX1, which further confirms their utility as a potential biomarker for early-stage detection of EOC. This evidence concerns the gene HOXA9 and ovarian carcinoma.